Advertisement

Basic Biochemistry of Prostaglandin Metabolism with Especial Reference to PGDH

  • Roderick J. Flower
Part of the NATO Advanced Study Institutes Series book series

Abstract

The mammalian organism possesses extremely efficient mechamisms for the catabolism of PGs and hence their biological inactivation. The effeciency of certain vascular beds — for example, the lung — in inactivating PGs is well illustrated by the observations of Ferreira and Vane (18), who found that more than 95% of infused PGE2 was inactivated during one circulation through the lungs and by those of Hamberg and Samuelsson (26), who showed that only 3% of an intravenous bolus injection of tritiated PGE2 remained in the plasma after 90 s. After 4.5 min there was no detectable PGE2 at all.

Keywords

Basic Biochemistry Niflumic Acid Crude Enzyme Preparation Smooth Muscle Preparation Relative Reaction Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. Anggard, The biological activities of three metabolites of prostaglandin El. Acta physiol. scand., 66: 509–511 (1966).PubMedCrossRefGoogle Scholar
  2. 2.
    E. Anggard, C. Larsson and B. Samuelsson, The distribution of 15-hydroxyprostaglandin dehydrogenase and prostaglandin A13 reductase in tissues of the swine. Acta Physiol. Scand., 81: 396–404 (1971).PubMedCrossRefGoogle Scholar
  3. 3.
    E. Anggard and B. Samuelsson, Prostaglandins and related factors. 28. Metabolism of prostaglandin El in guinea pig lungs: the structures of two metabolites. J. biol. Chem., 239: 4087–4102 (1964).Google Scholar
  4. 4.
    E. Anggard and B. Samuelsson, Purification and properties of a 15-hydroxy prostaglandin dehydrogenase from swine lung. Prostaglandins and related factors 55. Ark. kemi, 25: 293–300 (1966).Google Scholar
  5. 5.
    E. Anggard and B. Samuelsson, The metabolism of prostaglandins in lung tissue. In: “Prostaglandins”, Nobel Symposium 2, New York, Interscience, pp. 97–105 (1967).Google Scholar
  6. 6.
    J. M. Armstrong, G. J. Blackwell, R. J.Flower, J. C. McGiff, K. M. Mullane and J. R. Vane, Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature, 260: 582–586 (1976).Google Scholar
  7. 7.
    J. R. Bedwani and P. B. Marley, Increased inactivation of prostaglandin E2 by the rabbit lung during pregnancy. Br. J. Pharmcol., 50: 459P (1974).Google Scholar
  8. 8.
    A. Bennett, Prostaglandin antagonists. In: “Advances in Drug Research”, A. B. Simmonds, ed. Academic Press, London pp. 83–118 (1975).Google Scholar
  9. 9.
    L. Z. Bito, Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitro. J. Physiol., 221: 371–387 (1972).PubMedGoogle Scholar
  10. 10.
    G. J. Blackwell and R. J. Flower, Effects of steroid hormones on tissue levels of prostaglandin 15-hydroxydehydrogenase in the rat. Br. J. Pharmac., 56: 343P (1976).Google Scholar
  11. 11.
    G. J. Blackwell, R. J. Flower and J.R. Vane, Rapid reduction of prostaglandin 15-hydroxydehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors. Br. J. Pharmac., 55: 233–238 (1975).CrossRefGoogle Scholar
  12. 12.
    D. J. Crutchley and P. J. Piper, Prostaglandin inactivation in guinea pig lung and its inhibition. Br. J. Pharmac., 52: 197–203 (1974).CrossRefGoogle Scholar
  13. 13.
    D. J. Crutchley and P. J. Piper, Inhibition of the pulmonary inactivation of prostaglandins in rabbit in vivo. Br. J. Pharmac., 53: 467P (1975).Google Scholar
  14. 14.
    W. Dawson, J. R. Boot, A. F. Cockerill, D. N. B. Mallen and D. J. Osborne, Release of novel prostaglandins and thromboxanes after immunological challenge of guinea-pig lung, Nature, Lond., 262: 699 (1976).CrossRefGoogle Scholar
  15. 15.
    W. Dawson, R. L. Lewis, R. E. Macmahone and W. J. F. Sweatman, Potent bronchoconstrictor activity of 15-keto prostaglandin F. Nature (Lond.), 250: 331–332 (1974).CrossRefGoogle Scholar
  16. 16.
    W. Dawson, P. W. Ramwell and J. Shaw, Metabolism of prostaglandins by rat isolated liver. Br. J. Pharmac., 34: 668–669 (1968).Google Scholar
  17. 17.
    J. A. Salmon, G. Dusting, S. Moncada, K. Mullane and J. R. Vane, Elimination of prostacyclin (PGI2) and 6-oxo-PGF in anaesthetized dogs. J. Pharm. Pharmac., 31: 529–532 (1978).CrossRefGoogle Scholar
  18. 18.
    S. H. Ferreira, and J. R. Vane, Prostaglandins: their disappearance from and release into the circulation. Nature (Lond.) 216: 868–873 (1967).Google Scholar
  19. 19.
    R. J. Flower, Drugs which inhibit prostaglandin biosynthesis. Pharmac. Rev., 26: 33–67 (1974).Google Scholar
  20. 20.
    J. Fried, M. M. Mehrer and B. J. Gaede, Novel selective inhibitors of human placental PG-15-dehydrogenase. In: Supplement to “Advances in the Biosciences”, vol.9. International Conference on Prostaglandins, S. Bergstrom and S. Bernhard, eds., Vienna, Pergamon Press, Viewig, Braunschweig, p. 18 (1973).Google Scholar
  21. 21.
    E. Granström, On the metabolism of prostaglandin F in female subjects. Structures of two C14 metabolites. Eur. J. Biochem., 25: 581–589 (1972).PubMedCrossRefGoogle Scholar
  22. 22.
    E. Granström and B. Samuelsson, On the metabolism of prostaglandin F in female subjects. J. biol. Chem., 246: 5254–5263 (1971a).PubMedGoogle Scholar
  23. 23.
    E. Granström and B. Samuelsson, On the metabolism of prostaglandin F in female subjects II. Structures of six metabolites. J. biol. Chem., 246: 7470–7485 (1976).Google Scholar
  24. 24.
    E. Granström and B. Samuelsson, Structure of a deoxyprostaglandin in man. J.Am.Chem.Soc., 94: 4380–4381 (1972).PubMedCrossRefGoogle Scholar
  25. 25.
    K. Green and B. Samuelsson, Quantitative studies on the synthesis in vivo of prostaglandins in the rat. Cold stress induced stimulation of synthesis. Eur. J. Biochem., 22: 39 1–395 (1971).Google Scholar
  26. 26.
    M. Hamberg and B. Samuelsson, On the metabolism of prostaglandins E1 and E2 in man. J. biol. Chem., 246: 6713–6721 (1971).PubMedGoogle Scholar
  27. 27.
    M. Hamberg and B. Samuelsson, On the metabolism of prostaglandins E1 and E1 in the guinea pig. J. biol. Chem., 247: 3495–3502 (1972).PubMedGoogle Scholar
  28. 28.
    M. Hamberg and M. Wilson, Structures of new metabolites of postaglandin E2 in man, In: “Advances in the Biosciences”, S. Bergstrom ed., Vol.9, Pergamon Press, Oxford, p. 39 (1973).Google Scholar
  29. 29.
    H. S. Hansen, Inhibition by indomethacin and aspirin of 15-hydroxy prostaglandin dehydrogenase in vitro. Prostaglandins, 8: 95–105 (1974).PubMedGoogle Scholar
  30. 30.
    E. W. Horton and R. L. Jones, Prostaglandins Al A2 and 19hydroxy Al; their actions on smooth muscle and their inactivation of passage through the pulmonary and hepatic portal vascular beds. Br. J. Pharmacol., 37: 705–722 (1969).PubMedCrossRefGoogle Scholar
  31. 31.
    J. R. S. Hoult and P. K. Moore, Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: Possible basis for therapeutic action in ulcerative colitis. Br. J. Pharmac., 64: 6–8 (1968).CrossRefGoogle Scholar
  32. 32.
    H. R. Jackson, R. D. Hall, R. L. Hodge, E. L. Gibson, F. P. Katik and M. Stevens, The effect of aspirin on the pulmonary extraction of PGF2a and the cardiovascular response to PGF. Aust. J. Exp. Biol. Med. Sci., 51: 837–846 (1973).PubMedCrossRefGoogle Scholar
  33. 33.
    R. L. Jones, 15-hydroxy–9-oxoprosta–11, 13-dienoic acid as the product of a prostaglandin isomerase. J. Lipid. Res., 13: 511–518 (1972).PubMedGoogle Scholar
  34. 34.
    R. L. Jones, Actions of prostaglandins on the arterial system of the sheep: some structure-activity relationships. Br. J. Pharmac., 53: 464P (1975).Google Scholar
  35. 35.
    J. Kloeze, Relationship between chemical structures and platelet-aggregation activity of prostaglandins. Biochim. biophys. Acta., 187: 285–292 (1969).PubMedCrossRefGoogle Scholar
  36. 36.
    A. H. Labrum, M. Lipkin Jr., and F. Dray, Hyperprostaglandinaemia a previously unrecognised syndrome. In: “Advances in Prostaglandin and Thromboxane Research,” Samuelsson and Paoletti”,eds., Raven Press, New York, pp. 888–889 (1976).Google Scholar
  37. 37.
    S-C. Lee and L. Levine, Prostaglandin metabolism. I. cytoplasmic reduced nicotinamide adenine dinucleotide phospate - dependent and microsomal reduced nicotinamide adenine dinucleotide - dependent prostaglandin E 9-keto reductase activities in monkey and pigeon tissues. J. biol. Chem., 249: 1369–1375 (1974).Google Scholar
  38. 38.
    S-C. Lee, S-S Pong, D. Katzen, K-Y Wu and L. Levine, Distribution of prostaglandin E 9-keto reductase and types I and II 15-hydroxy dehydrogenase in swine kidney, medullar and cortex. Biochemistry, 14: 142–145 (1975).Google Scholar
  39. 39.
    L. Levine, R. M. Gutierrez-Cernosek and H. Van Vunakis, Advances in the Biosciences (S. Bergstrom, ed.) Vol. 9, Pergamon Press, Oxford, p.71 (1973).Google Scholar
  40. 40.
    M. A. Marrazzi and N. H. Andersen, Prostaglandin dehydrogenase. In: “The Prostaglandins,” P. Ramwell, ed., Vol 2, Plenum Press, New York, pp. 99–155 (1974).Google Scholar
  41. 41.
    M. A. Marrazzi and F. M. Matschinsky, Properties of 15-hydroxyprostaglandin dehydrogenase: structural requirements for substrate binding. Prostaglandins, 1: 373–388 (1972).PubMedGoogle Scholar
  42. 42.
    M. A. Marrazzi, J. E. Shaw, F. T. Tao and F. M. Matschinsky, Reversibility of 15-hydroxy prostaglandin dehydrogenase from swine lung. Prostaglandins, k: 389–395 (1972).Google Scholar
  43. 43.
    J. C. McGiff, N. A. Terragno, J. C. Strand, J. B. Lee, A. J. Lonigro and K. K. F. Ng, Selective passage of prostaglandins across the lung. Nature (Lond.), 223: 742–745 (1969).CrossRefGoogle Scholar
  44. 44.
    J. Nakano, Metabolism of prostaglandin E1 in dog kidneys. Br. J. Pharmac., 40: 317–325 (1970a).CrossRefGoogle Scholar
  45. 45.
    J. Nakano, Metabolism of prostaglandin El (PGE1) in kidney and lung. Fed. Proc., 29: 746 (1970b).Google Scholar
  46. 46.
    J. Nakano, Effects of the metabolites of prostaglandin E1 of the systemic and peripheral circulation in dogs. Proc. Soc. exp. Biol. (N.Y.), 136: 1265–1268 (1971).PubMedGoogle Scholar
  47. 47.
    J. Nakano, E. Angggard and B. Samuelsson, 15-hydroxy prostanoate dehydrogenase. Prostaglandins as substrates and inhibitors. Eur. J. Biochem., 11: 386–389 (1969).PubMedCrossRefGoogle Scholar
  48. 48.
    J. Nakano and N. H. Morsy, Beta-oxidation of prostaglandins El and E2 in rat lung and kidney homogenates. Clin. Res., 19: 142 (1971).Google Scholar
  49. 49.
    J. Nakano. B. Montague and B. Darrow, Metabolism of prostaglandin E1 in human plasma, uterus and placenta in swine ovary and rat testicle. Biochem. Pharmacol., 20: 2512–2514 (1971).Google Scholar
  50. 50.
    J. Nakano and A. V. Prancan, Metabolic degradation of prostaglandin E1 in the rat plasma and in the rat brain, heart, lung, kidney and testicle homogenates. J. Pharm. (Loud.), 23: 231–232 (1971).Google Scholar
  51. 51.
    J. Nakano and A. V. Prancan, Metabolic degradation of prostaglandin El in the lung and kidney of rats in endotoxin shock. Proc. Soc. exp. Biol. (N.Y.), 144: 506–508 (1973).PubMedGoogle Scholar
  52. 52.
    H. M. Nissen, and H. Andersen, On the localization of a prostaglandin dehydrogenase activity in the kidney. Histochemie, 14: 189: 200 (1968).Google Scholar
  53. 53.
    H. M. Nissen and H. Andersen, On the activity of prostaglandin dehydrogenase system in the kidney. A histo-chemical study during hydration-dehydration and salt-repletion-depletion. Histochemie, 17: 241–247 (1969).PubMedCrossRefGoogle Scholar
  54. 54.
    C. R. Pace-Asciak, M. C. Carrara and Z. Domazet, 1977a, Identification of the major urinary metabolites of 6-keto prostaglandin F(6k-PGF1) in the rat. Biochem. biophys. Res. Commun., 78:115–121 a(1977a).PubMedCrossRefGoogle Scholar
  55. 55.
    C. R. Pace-Asciak, Z. Domazet and M. Carrara, Catabolism of 6-keto prostaglandin Fia by the rat kideny crotex. Biochim. jpDhvs. Acta., 487: 400–404 (1977b).CrossRefGoogle Scholar
  56. 56.
    C. Pace-Asciak and D. Miller, Prostaglandins during development. I. age dependent activity profiles of prostaglandin 15-hydroxy-dehydrogenase and 13,14-reductase in lung tissue from late pre-natal, early post-natal and adult rats. Prostaglandins, 4: 351–362 (1973).PubMedGoogle Scholar
  57. 57.
    D. G. Parkes and T. E. Eling, Characterization of prostaglandin synthetase in guinea pig lung. Isolation of a new prostaglandin derivative from arachidonic acid. Biochemistry, 13: 2598: 2604 (1974).Google Scholar
  58. 58.
    D. G. Parkes and T. E. Eling, The influence of environmental agents on prostaglandin dehydrogenase in vitro. Prostaglandin biosynthesis and metabolism in the lung. Biochem. J., 146: 549–556 (1975).PubMedGoogle Scholar
  59. 59.
    T. M. Parkinson and J. C. Schneider, Absorption and metabolism of prostaglandin E1 by perfused rat jejunum in vitro. Biochim. biophys. Acta., 176: 78 (1969).PubMedCrossRefGoogle Scholar
  60. 60.
    J. E. Pike, F. P. Kupiecki and J. R. Weeks, Biological activity of the prostaglandins and related analogies, In:”Prostaglandins”, Nobel Symposium, Vol.II, New York, Interscience, pp.161–171 (1967).Google Scholar
  61. 61.
    P. J. Piper, J. R. Vane and J. H. Wyllie, Inactivation of prostaglandins by the lungs. Nature, 225: 600–604 (1970).PubMedCrossRefGoogle Scholar
  62. 62.
    H. Polet and L. Levine, Serum prostaglandin A isomerase. Biochem. biophys. Res. Commun., 45: 1169–1176 (1971).PubMedCrossRefGoogle Scholar
  63. 63.
    L. J. Roberts, B. J. Sweetman, N. A. Payne and J. A. Oates, Metabolism of thromboxane B2 in the monkey,. J.biol. Chem. 252: 7415–7417 (1977).PubMedGoogle Scholar
  64. 64.
    J. W. Ryan, R. S. Niemeyer and D. W. Goodwin, Metabolic rates of bradykinin, angiotensin I, adenine nucleotides and prostaglandins E1 and F in the pulmonary circulation. Adv. Exp. Med. Biol., 21: 259–265 (1972).CrossRefGoogle Scholar
  65. 65.
    S. A. Saeed and A. C. Roy, Purification of 15-hydroxy prostaglandin dehydrogenase from bovine lung. Biochem. Biophys. Res. Commun., 47: 96–102 (1972).PubMedCrossRefGoogle Scholar
  66. 66.
    B. Samuelsson, Structures, biosynthesis and metabolism of prostaglandins. In:”Lipid Metabolism,” New York-London, Academic Press, pp.107–153 (1970).CrossRefGoogle Scholar
  67. 67.
    B. Samuelsson, E. Granstrom, K. Green and M. Hamberg, Metabolism of prostaglandins. Ann.N.Y.Acad.Sci., 180: 138–163 (1971).Google Scholar
  68. 68.
    G. E. Sander and C. G. Huggins, Subcellular localization of angiotensin I converting enzyme in rabbit lung. Nature, New Biol., 230: 27–29 (1971).Google Scholar
  69. 69.
    H. Shio, P. W. Ramwell, N. A. Andersen and E. J. Corey, Stereospecificity of the prostaglandin 15-dehydrogenase from swine lung. Experientia, 26: 335–357 (1970).CrossRefGoogle Scholar
  70. 70.
    M. J. H. Smith and P. D. Dewkins, Salicylate and enzymes. J. Pharm. Pharmacol., 23: 729–744 (1971).PubMedCrossRefGoogle Scholar
  71. 71.
    K. J. Stone and M. Hart, Prostaglandin-E2–9-Ketoreductase in rabbit kidney, Prostaglandins, 10: 273 (1975).PubMedGoogle Scholar
  72. 72.
    D. D. Sun, Metabolism of prostaglandin F in the rat. Biochem. Biophys. Acta., 348: 249–262 (1974).CrossRefGoogle Scholar
  73. 73.
    F. F. Sun and S. B. Armour, Prostaglandin 15-hydroxy dehydrogenase and 13 reductase levels in the lungs of maternal fetal, and neonatal rabbits. Prostaglandin, 7: 327–338 (1974).Google Scholar
  74. 74.
    F. F. Sun, J. C. McGuire and B. M. Taylor, Presentation at the Winter Meeting on Prostaglandins at Sarasota, Florida, USA, January, 1978.Google Scholar
  75. 75.
    F. F. Sun and J. E. Stafford, Metabolism of PGF in rhesus monkey. Biochim. Biophys. Acta., 369: 95–110 (1974).PubMedCrossRefGoogle Scholar
  76. 76.
    H. Vonkeman, D. H. Nugteren and D. A. Van Dorp., The action of prostaglandin 15-hydroxy dehydrogenase on various prostaglandins. Biochim. Biophys. Acta., 187: 581–583 (1969).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Roderick J. Flower
    • 1
  1. 1.Department of Prostaglandin ResearchWellcome Research Laboratories Langley CourtBeckenham, KentUK

Personalised recommendations